41 results
Page 2 of 3
6-K
EX-1.1
xv6b 5uvb7
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
xh51acka yjcq
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
yy992ff4
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
3o5v md7t
20 Nov 19
Prospectus supplement for primary offering
4:46pm
F-3
fzjgpt2
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
EX-99.3
fyfd0aatvwmy
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.4
wmrhrz 7uzo6hcw2z
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
n6d zb6y1zy
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
595f2dxjipr
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.2
4ko9lb5gcl0qzl
19 Nov 18
Agreement and Plan of Merger
4:34pm
20-F
0kx065fg6f lbup88o
31 Mar 15
Annual report (foreign)
12:00am
424B4
jmwur0qihffsojgsn
31 Jul 14
Prospectus supplement with pricing info
12:00am
CORRESP
gh2a9cs3cy b21c2jk
28 Jul 14
Correspondence with SEC
12:00am